CE-STAND: Cervical Epidural STimulation After Neurologic Damage

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
University of Minnesota
Study ID
NCT06410001
Phase
PHASE1/PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Spinal Cord Injury

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Epidural Spinal Cord Stimulation System — DEVICE
    Abbott Eterna system implantable pulse generator (IPG), charger, and TriCentrus lead

Study Details

CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.

Key Dates

Start date
Mar 15, 2026
Status verified
Mar 2026
Primary completion
May 31, 2030
Completion
Jul 30, 2030

Study Design

Enrollment
36 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Spinal injury patients
    Experimental: Individuals with cervical SCI comparing stimulation "on" vs "off" longitudinally.

Primary Outcome Measure

Safety of epidural spinal cord stimulator in chronic cervical patients [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MinnesotaMinneapolisMinnesota55455
Ann Parr, MD, PhD
[email protected]
612-625-4102

Find similar trials in Minneapolis, MN

By research site
University of Minnesota· Minneapolis, MN

Related Studies